Kindred Biosciences Competitors and Similar CompaniesClear all

Kindred Biosciences's competitors and similar companies include Agrovet Market Animal Health, ECO Animal Health Group, Aurora Pharmaceutical and LLOYD.

	Kindred Biosciences Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.	Agrovet Market Animal Health Agrovet Market Animal Health is a company dedicated to the development and export of products for veterinary use.	ECO Animal Health Group ECO Animal Health Group is an animal health biotechnology company.	Aurora Pharmaceutical Aurora Pharmaceutical is a veterinary pharmaceutical product development and manufacturing company.	LLOYD LLOYD is a company that manufactures and markets nutritional and pharmaceutical products.
Founding Date	Founding Date 2013	Founding Date 1994	Founding Date 1972	Founding Date 2009	Founding Date 1958
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary	Tags Healthcare biotech drug development pharma veterinary
Locations	Locations Burlingame, US HQ Burlingame, US San Diego, US Wathena, US	Locations Cercado de Lima, PE HQ	Locations London, GB HQ Vinhedo, BR Huzhou, CN Dublin, IE Tokyo, JP Santiago De Querétaro, MX Urbandale, US	Locations Northfield, US HQ	Locations Shenandoah, US HQ
Employees	Employees 1567% increase	Employees 2551% increase	Employees 2241% decrease	Employees 823% increase	Employees 95
Financial
Revenue (est.)	Revenue (est.) $42.2m (FY, 2020)	Revenue (est.) N/A	Revenue (est.) £79.6m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $4.6m (FY, 2020)	Cost of goods N/A	Cost of goods £40.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $37.5m (FY, 2020)	Gross profit N/A	Gross profit £39.1m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($21.8m) (FY, 2020)	Net income N/A	Net income £2.6m (FY, 2025)	Net income N/A	Net income N/A